Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Estimates of the worldwide incidence of eighteen major cancers in 1985.

Parkin DM, Pisani P, Ferlay J.

Int J Cancer. 1993 Jun 19;54(4):594-606.

PMID:
8514451
2.

Base transitions are the most frequent genetic changes at P53 in gastric cancer.

Renault B, van den Broek M, Fodde R, Wijnen J, Pellegata NS, Amadori D, Khan PM, Ranzani GN.

Cancer Res. 1993 Jun 1;53(11):2614-7.

3.

Clues to the pathogenesis of familial colorectal cancer.

Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin JP, Järvinen H, Powell SM, Jen J, Hamilton SR, et al.

Science. 1993 May 7;260(5109):812-6.

PMID:
8484121
4.

Genetic mapping of a locus predisposing to human colorectal cancer.

Peltomäki P, Aaltonen LA, Sistonen P, Pylkkänen L, Mecklin JP, Järvinen H, Green JS, Jass JR, Weber JL, Leach FS, et al.

Science. 1993 May 7;260(5109):810-2.

PMID:
8484120
5.

Epidemiology of colorectal adenomatous polyps.

Neugut AI, Jacobson JS, De Vivo I.

Cancer Epidemiol Biomarkers Prev. 1993 Mar-Apr;2(2):159-76. Review. No abstract available.

6.

Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage.

Spruck CH 3rd, Rideout WM 3rd, Olumi AF, Ohneseit PF, Yang AS, Tsai YC, Nichols PW, Horn T, Hermann GG, Steven K, et al.

Cancer Res. 1993 Mar 1;53(5):1162-6. Erratum in: Cancer Res 1993 May 15;53(10 Suppl):2427.

7.

Apoptosis (the 1992 Frank Rose Memorial Lecture).

Wyllie AH.

Br J Cancer. 1993 Feb;67(2):205-8. Review.

8.

Clinical implications of the p53 tumor-suppressor gene.

Harris CC, Hollstein M.

N Engl J Med. 1993 Oct 28;329(18):1318-27. Review. No abstract available.

PMID:
8413413
9.

p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.

Hsu IC, Tokiwa T, Bennett W, Metcalf RA, Welsh JA, Sun T, Harris CC.

Carcinogenesis. 1993 May;14(5):987-92.

PMID:
8389256
10.

p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand.

Hollstein MC, Wild CP, Bleicher F, Chutimataewin S, Harris CC, Srivatanakul P, Montesano R.

Int J Cancer. 1993 Jan 2;53(1):51-5.

PMID:
8380058
11.

A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men.

Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Kearney J, Willett WC.

J Natl Cancer Inst. 1994 Feb 2;86(3):183-91.

PMID:
8283490
12.

p53: at the crossroads of molecular carcinogenesis and risk assessment.

Harris CC.

Science. 1993 Dec 24;262(5142):1980-1. Review. No abstract available.

PMID:
8266092
13.
14.

Colon cancer: a review of the epidemiology.

Potter JD, Slattery ML, Bostick RM, Gapstur SM.

Epidemiol Rev. 1993;15(2):499-545. Review. No abstract available.

PMID:
8174669
15.

Cholecystectomy and colorectal cancer in China.

Zeng ZS, Zhang ZF.

Surg Oncol. 1993 Dec;2(6):311-9.

PMID:
8130937
16.

The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.

Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M, Welsh D.

Br J Cancer. 1994 Mar;69(3):409-16. Review.

17.

Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer.

Zhang ZF, Sarkis AS, Cordon-Cardo C, Dalbagni G, Melamed J, Aprikian A, Pollack D, Sheinfeld J, Herr HW, Fair WR, et al.

Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):19-24.

18.

Immunohistochemical analysis of p53 overexpression in human colonic tumors.

Darmon E, Cleary KR, Wargovich MJ.

Cancer Detect Prev. 1994;18(3):187-95.

PMID:
8076381
19.

Statistical analysis of molecular epidemiology studies employing case-series.

Begg CB, Zhang ZF.

Cancer Epidemiol Biomarkers Prev. 1994 Mar;3(2):173-5.

20.

p53 nuclear overexpression: an independent predictor of survival in lymph node--positive colorectal cancer patients.

Zeng ZS, Sarkis AS, Zhang ZF, Klimstra DS, Charytonowicz E, Guillem JG, Cordon-Cardo C, Cohen AM.

J Clin Oncol. 1994 Oct;12(10):2043-50.

PMID:
7931472
Items per page

Supplemental Content

Write to the Help Desk